RelA regulates the survival of activated effector CD8 T cells

Cell Death and Differentiation

Volumn 12, Issue 11, 2005, Pages 1398-1406

  Mondor, I ^a   Schmitt Verhulst, A M ^a   Guerder, S ^a  

^a INSERM   (France)

Author keywords

Cellular activation; Cellular proliferation; Memory; T lymphocytes; Transcription factors

Indexed keywords

CD8 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P50; SYNAPTOTAGMIN; T LYMPHOCYTE RECEPTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL CYCLE; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; GEL MOBILITY SHIFT ASSAY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BINDING SITES; CD8-POSITIVE T-LYMPHOCYTES; CELL GROWTH PROCESSES; CELL SURVIVAL; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; PROTEIN STRUCTURE, TERTIARY; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA;

ANIMALIA;

EID: 27344439684     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401673     Document Type: Article

References (52)

1. Ghosh S, May MJ and Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260
2. Zhong H, Voll RE and Ghosh S (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1: 661-671
3. Zhong H, May MJ, Jimi E and Ghosh S (2002) The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9: 625-636
4. Campbell KJ, Roche S and Perkins ND (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol. Cell 13: 893-865
5. Boothby M, Mora A, Schere D, Brockman J and Ballard D (1997) Perturbation of the T lymphocyte lineage in trangenic mice expressing a constitutive repressor of nuclear factor (NF)-kB. J. Exp. Med. 185: 1897-1907
6. Ferreira V, Sidenius N, Tarantino N, Hubert P, Chatenoud L, Blasi F and Korner M (1999) In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoissis. J. Immunol. 162: 6442-6450
7. Wan YY and DeGregori J (2003) The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression. Immunity 18: 331-342
8. Mora AL, Com RA, Stanic AK, Goenka S, Aronica M, Stanley S, Ballard DW, Joyce S and Boothby M (2003) Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: Roles of Fas, c-FLIP, and Bcl-xL. Cell Death Differ. 10: 1032-1044
9. Hettmann T, Opferman JT, Leiden JM and Ashton-Rickardt PG (2003) A critical role for NF-kappaB transcription factors in the development of CD8+ memory-phenotype T cells. Immunol. Lett. 85: 297-300
10. Kolenko V, Bloom T, Rayman P, Bukowski R, Hsi E and Finke J (1999) Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J. Immunol. 163: 590-598
11. Kahn-Perles B, Lipcey C, Lecine P, Olive D and Imbert J (1997) Temporal and subunit-specific modulations of the Rel/NF-kappaB transcription factors through CD28 costimulation. J. Biol. Chem. 272: 21774-21783
12. Doi TS, Takahashi T, Taguchi O, Azuma T and Obata Y (1997) NF-kappa B RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185: 953-961
13. Zheng Y, Ouaaz F, Bruzzo P, Singh V, Gerondakis S and Beg AA (2001) NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. J. Immunol. 166: 4949-4957
14. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D and Gerondakis 8 (1995) Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9: 1965-1977
15. Gerondakis S, Strasser A, Metcalf D, Grigoriadis G, Scheerlinck JY and Grumont RJ (1996) Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 93: 3405-3409
16. Liou HC, Jin Z, Tumang J, Andjelic S, Smith KA and Liou ML (1999) c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 11: 361-371
17. Zheng Y, Vig M, Lyons J, Van Parijs L and Beg AA (2003) Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J. Exp. Med. 197: 861-874
18. Hettmann T and Leiden JM (2000) NF-kappa B is required for the positive selection of CD8+ thymocytes. J. Immunol. 165: 5004-5010
19. Hettmann T, DiDonato J, Karin M and Leiden JM (1999) An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189: 145-158
20. Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH and Winkler H (1997) Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B. J. Clin. Invest. 99: 763-772
21. Soares MP, Muniappan A, Kaczmarek E, Koziak K, Wrighton CJ, Steinhauslin F, Ferran C, Winkler H, Bach FH and Anrather J (1998) Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. J. Immunol. 161: 4572-4582
22. Schmitz ML and Baeuerle PA (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 10: 3805-3817
23. Kunsch C, Ruben SM and Rosen CA (1992) Selection of optimal kappa B/Rel DNA-binding motifs: Interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12: 4412-4421
24. Chan H, Bartos DP and Owen-Schaub LB (1999) Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment Mol. Cell. Biol. 19: 2098-2108
25. Chen C, Edelstein LC and Gelinas C (2000) The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20: 2687-2695
26. Cheng O, Cant CA, Moll T, Hofer-Warbinek R, Wagner E, Birnstiel ML, Bach FH and de Martin R (1994) NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J. Biol. Chem. 269: 13551-13557
27. Cogswell PC, Scheinman RI and Baldwin Jr AS (1993) Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL. J. Immunol. 150: 2794-2804
28. Ghosh P, Tan TH, Rice NR, Sica A and Young HA (1993) The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: C-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA 90: 1696-1700
29. Grumont RJ, Rourke IJ and Gerondakis S (1999) Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13: 400-411
30. Khoshnan A, Tindell C, Laux I, Bae D, Bennett B and Nel AE (2000) The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J. Immunol. 165: 1743-1754
31. Com RA, Aronica MA, Zhang F, Tong Y, Stanley SA, Kim SR, Stephenson L, Enerson B, McCarthy S, Mora A and Boothby M (2003) T cell-intrinsic requirement for NF-kappaB induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response. J. Immunol. 171: 1816-1824
32. Lopez-Cabrera M, Munoz E, Blazquez MV, Ursa MA, Santis AG and Sanchez-Madrid F (1995) Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J. Biol. Chem. 270: 21545-21551
33. Matsui K, Fine A, Zhu B, Marshak-Rothstein A and Ju ST (1998) Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter. functional analysis in T cell hybridoma. J. Immunol. 161: 3469-43473
34. Pierce JW, Jamieson CA, Ross JL and Sen R (1995) Activation of IL-2 receptor alpha-chain gene by individual members of the rel oncogene family in association with serum response factor. J. Immunol. 155: 1972-1980
35. Stade BG, Messer G, Riethmuller G and Johnson JP (1990) Structural characteristics of the 5′ region of the human ICAM-1 gene. Immunobiology 182: 79-87
36. Scott ML, Fujita T, Liou HC, Nolan GP and Baltimore D (1993) The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. 7: 1266-1276
37. Singer GG and Abbas AK (1994) The fas antigen is involved in peripheral but not thymic deletion of lymphocytes in T cell receptor transgenic mice. Immunity 1: 365-371
38. Van Parijs L, Ibraghimov A and Abbas AK (1996) The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4: 321-328
39. Zong WX, Edelstein LC, Chen C, Bash J and Gelinas C (1999) The prosurvivall Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13: 382-387
40. Van Parijs L, Peterson DA and Abbas AK (1998) The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8: 265-274
41. Hildeman DA, Zhu Y, Mitchell TC, Bouillet P, Strasser A, Kappler J and Marrack P (2002) Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16: 759-767
42. Beg AA and Baltimore D (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274: 782-784
43. Liu Z-G, Hsu H, Goeddel D and Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death. Cell 87: 565-576
44. Van Antwerp D, Martin S, Kafri T, Green D and Verma I (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274: 787-789
45. Wang C, Mayo M and Baldwin Jr A (1996) TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274: 784-787
46. Prendes M, Zheng Y and Beg AA (2003) Regulation of developing B cell survival by RelA-containing NF-kappaB complexes. J. Immunol. 171: 3963-3969
47. Schönrich G, Kalinke U, Momburg F, Malissen M, Schimtt-Verhulst A-M, Malissen B, Hammerling GJ and Arnold B (1991) Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65: 293-304
48. Kurata H, Lee HJ, O'Garra A and Arai N (1999) Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11: 677-688
49. Morita S, Kojima T and Kitamura T (2000) Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066
50. Guerder S, Rincon M and Schmitt-Verhulst AM (2001) Regulation of activator protein-1 and NF-kappaB in CD8(+) T cells exposed to peripheral self-antigens. J. Immunol. 166: 4399-4407
51. Wurtz O, Pophillat M, Schmitt-Verhulst AM and Guerder S (2002) A novel reporter strain to follow Cre-mediated recombination in T and NK cells. Genesis 32: 287-292
52. Bajenoff M, Wurtz O and Guerder S (2002) Repeated antigen exposure is necessary for the differentiation, but not the initial proliferation, of naive CD4(+) T cells. J. Immunol. 168: 1723-1729